KEYS Keysight Technologies, Inc.
Industrial Instruments For Measurement, Display, and Control · NYSE · SEC CIK 1601046 · Fiscal year ends 10/31
Financial factors as of 2026-07-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY25.5%
TTM net income YoY131.6%
TTM EPS YoY131.1%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR3.7%
Margins
Gross margin64.7%
Operating margin20.3%
Net margin19.1%
FCF margin22.3%
EBITDA margin22.5%
Returns
ROE20.6%
ROA11.2%
ROIC (approx.)21.3%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets44.9%
Debt / equity0.38x
Current ratio2.02x
Interest coverage12.34x
Cash quality & payout
Operating cash flow / net income1.27x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-10-31 | FY20242024-10-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.38B | $4.98B |
| Cost of revenue | $2.04B | $1.85B |
| Gross profit | $3.34B | $3.13B |
| R&D expense | $1.01B | $919.00M |
| SG&A expense | $1.47B | $1.40B |
| Operating income | $876.00M | $833.00M |
| Interest expense | $96.00M | $84.00M |
| Pretax income | $1.08B | $865.00M |
| Income tax | $213.00M | $251.00M |
| Net income | $850.00M | $614.00M |
| EBITDA | $1.01B | $959.00M |
| EPS (basic) | 4.93 | 3.53 |
| EPS (diluted) | 4.91 | 3.51 |
| Weighted avg. shares (diluted) | 173.00M | 175.00M |
| Balance sheet | ||
| Cash & equivalents | $1.87B | $1.81B |
| Receivables | $939.00M | $857.00M |
| Inventory | $1.05B | $1.02B |
| Current assets | $4.35B | $4.26B |
| PP&E, net | $795.00M | $774.00M |
| Goodwill | $3.42B | $2.39B |
| Intangibles | $1.30B | $607.00M |
| Total assets | $11.30B | $9.27B |
| Current liabilities | $1.85B | $1.43B |
| Short-term debt | $0 | $0 |
| Long-term debt | $2.53B | $1.79B |
| Total debt | $2.53B | $1.79B |
| Total liabilities | $5.42B | $4.16B |
| Shareholders' equity | $5.88B | $5.11B |
| Net debt | $661.00M | -$24.00M |
| Cash flow statement | ||
| Operating cash flow | $1.41B | $1.05B |
| Capital expenditure | $128.00M | $154.00M |
| Free cash flow | $1.28B | $898.00M |
| Investing cash flow | -$1.73B | -$819.00M |
| Financing cash flow | $385.00M | -$913.00M |
| Depreciation & amortization | $131.00M | $126.00M |
| Stock-based compensation | $162.00M | $137.00M |
| Share buybacks | $375.00M | $439.00M |
Free plan shows the latest 2 periods; Pro shows all 13 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.